E-GEOD-46062 - Gene expression of CD19+ b cells
Released on 18 April 2013, last updated on 3 June 2014
We used DNA microarray technology to assess changes in gene expression after treatment of 11 lymphoma cell lines with epigenetic drugs. We identified genes with upregulated expression in treated cell lines and with downregulated expression in B-cell lymphoma patient samples when compared to normal B cells. CD19+ b cells were isolated from buffy coats from diffrent healthy donors. Gene expression of healthy controls (CD19+ b cells) was used as a normal counterpart for lymphoma samples (GSE4732, GSE10846).
transcription profiling by array
Nicole Bethge <email@example.com>, Guro E Lind